Dementia: a barrier to receiving percutaneous coronary intervention for elderly patients with ST-elevated myocardial

Marianne Chanti-Ketterl1, Elizabeth Barnett Pathak, Ross Andel

  • 1School of Aging Studies, University of South Florida, Tampa, FL, USA.

Insights

Older adults with dementia are significantly less likely to undergo cardiac catheterization for ST-elevated myocardial infarction (STEMI). This limits their access to potentially life-saving treatments like percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG).

Area of Science:

  • Cardiology
  • Geriatrics
  • Neurology

Background:

  • Percutaneous coronary intervention (PCI) is a primary treatment for ST-elevated myocardial infarction (STEMI).
  • Dementia is a growing concern in the elderly population, impacting healthcare decisions and outcomes.
  • Evaluating treatment disparities in STEMI patients with dementia is crucial for equitable care.

Purpose of the Study:

  • To investigate the association between dementia and the utilization of diagnostic cardiac catheterization in STEMI patients aged 65 and older.
  • To determine if dementia influences the likelihood of receiving PCI or coronary artery bypass graft (CABG) among STEMI patients.

Main Methods:

  • Retrospective analysis of Florida inpatient data (2006-2007) for STEMI patients ≥65 years old.
  • Dementia diagnosis identified using ICD-9 codes.
  • Statistical analysis, including relative risk (RR) calculations, adjusted for demographic factors.

Main Results:

  • STEMI patients with dementia (3%) were significantly less likely to undergo cardiac catheterization (42% vs. higher for non-demented).
  • Among those catheterized, dementia did not affect PCI or CABG rates.
  • Factors reducing catheterization in dementia patients included older age and later hospital arrival; hyperlipidemia increased likelihood.

Conclusions:

  • Dementia is associated with substantially lower rates of diagnostic cardiac catheterization in elderly STEMI patients.
  • This disparity may restrict access to optimal reperfusion therapies, including PCI and CABG.
  • Further research is needed to address barriers and ensure equitable care for STEMI patients with cognitive impairment.
Abstract

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522